At the International AIDS Conference this week, numerous research are examining how cardiovascular disease, thinning bones and a listing of other health issues typically observed in the final years appear to hit many people who have HIV when they’re only in their 50s . The Washington Post: AGEING With HIV The difficulties of managing along with preventing HIV among old Americans were a significant theme at the 19th International AIDS Meeting in Washington this week, which closes Friday with a speech by former president Bill Clinton . McClatchy Papers: What Science Can’t However Treat: HIV’s Impact On Minorities, Poor For all your strides produced against HIV, the virus that triggers AIDS, science and medication by itself can’t end an epidemic that impacts vulnerable populations disproportionately: minorities, young people, poor people and the ones who lack usage of health care.Therapies that will become the standard of care years from now can be found today at SCCA as medical trials. As we identify even more driver mutations with actionable targeted therapies, I really believe that within 15 years, we'll develop effective treatments for a few of the most lethal cancers highly. Produced by Dr. Colin Pritchard, in collaboration with Tom Walsh, University of Washington Research Associate Professor of Medication in the Division of Medical Genetics and Mary-Claire King, University of Washington Professor of Medication and Genome Sciences, UW-OncoPlex introduces a more precise method of choosing the most efficient treatment for patients.